What is the approximate recurrence rate of colon cancer

What is the recurrence rate of colon cancer? The recurrence rate of colon cancer is as high as 30% to 50%. In order to prevent the increase of the recurrence rate and metastasis of colon cancer, patients should insist on regular follow-up after being discharged from the hospital after reasonable treatment. However, as time goes by, the importance of follow-up is ignored, which lays the hidden danger for the recurrence and metastasis of colon cancer.

Colon cancer surgery is better, with more than 50% of patients living at least 5 years after radical surgery. If the patient is in the early stage, it can reach more than 80%, and the recurrence rate of late-stage colon cancer is only about 30%. The cause of colon cancer has not been truly understood, and doctors have different opinions on whether colon cancer can be inherited. A foreign country once investigated a family, with more than 650 blood relatives in 75 years, of which 96 were malignant tumor patients, most of whom had colon cancer and adenocarcinoma of other organs. Others have found that the risk of colon cancer in the compatriots of colon cancer patients is 5 times higher than that of the general population, and familial factors of colon cancer are more common than other digestive tract cancers. Therefore, many doctors believe that genetic factors are related to colon cancer.
Postoperative chemotherapy is also essential to prevent the recurrence and metastasis of colon cancer after surgery. Chemotherapy should be appropriately assisted after colon cancer surgery to improve the success rate of surgery, which can effectively prevent the recurrence and metastasis of colon cancer. When it comes to chemotherapy, most patients are afraid of the series of toxic side effects brought about by chemotherapy, such as nausea, vomiting, anorexia and even hair loss. However, with the rapid development of medical technology, the emergence of targeted oral chemotherapy drugs has made innovative breakthroughs in chemotherapy drugs. Targeted oral chemotherapy drugs such as capecitabine are different from traditional chemotherapy drugs. After entering the human body, they must be under the action of enzymes in tumor cells to produce a killing effect, and they cause little damage to normal human cells.